Opportunity ID: 309081

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-19-014
Funding Opportunity Title: Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R43/R44 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 19, 2018
Last Updated Date:
Original Closing Date for Applications: Dec 14, 2018
Current Closing Date for Applications: Dec 14, 2018
Archive Date: Jan 19, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement is to develop and evaluate the loyalty/reward-based digital technologies (e.g., mobile medical app/device platforms and other digital technologies) to be used as a combination product to increase medication adherence. The objective of Phase I (R43) is to establish the feasibility and/or validation of the device, and Phase 2 is designed to test the efficacy of the reward-based platform in a larger sample. The primary endpoint is adherence to FDA-approved medications for substance use disorders. Rewards and contingencies should be delivered in a self-sustaining manner and include a front-end interface allowing treatment providers to monitor progress and deliver rewards. Platforms may include novel features including, but not limited to, automated tracking tools, real-time assessments of patient progress, medication intake, and momentary assessment. Data generated from these studies are to be used to support a 510k submission to seek clearance as an FDA cleared device.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-014.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00244969 Nov 14, 2018 Dec 14, 2018 View

Package 1

Mandatory forms

309081 RR_SF424_2_0-2.0.pdf

309081 PHS398_CoverPageSupplement_4_0-4.0.pdf

309081 RR_OtherProjectInfo_1_4-1.4.pdf

309081 PerformanceSite_2_0-2.0.pdf

309081 RR_KeyPersonExpanded_2_0-2.0.pdf

309081 RR_Budget_1_4-1.4.pdf

309081 PHS398_ResearchPlan_4_0-4.0.pdf

309081 SBIR_STTR_Information_1_2-1.2.pdf

Optional forms

309081 RR_SubawardBudget30_1_4-1.4.pdf

309081 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T08:20:55-05:00

Share This Post, Choose Your Platform!

About the Author: